Aug. 14, 2022 — Four main cruise strains are dropping their COVID-19 vaccination necessities for some sailings subsequent month, in keeping with USA Today.

Carnival Cruise Line gained’t require unvaccinated friends to use for an exemption to sail after Sept. 6. The modifications are topic to native restrictions, resembling these in Bermuda, Canada and Greece, and don’t embrace voyages in Australia or journeys which might be 16 or extra nights.

Princess Cruises will take away vaccination necessities on Sept. 6 for many voyages which might be lower than 16 days. The cruise line presently requires unvaccinated friends to have a vaccine exemption earlier than they sail.

Royal Caribbean Group, which incorporates Royal Caribbean International and Celebrity Cruises, will welcome all vacationers no matter vaccination standing starting Sept. 5 “as long as testing requirements are met,” a spokesperson instructed USA Today.

For Royal Caribbean, the modifications embrace sailings from Los Angeles, New Orleans, Galveston and Europe. For Celebrity, meaning cruises leaving from Los Angeles, the U.Okay. and Europe — however not Ireland. Bahamas and Caribbean cruises that depart from Florida ports nonetheless have vaccine guidelines in place.

The bulletins got here on Friday after Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises mentioned Monday that unvaccinated passengers could be allowed on many cruises beginning Sept. 3, in keeping with The Washington Post. The cruise strains, that are a part of the identical guardian firm, additionally dropped all pre-cruise necessities for vaccinated passengers. Those who’re unvaccinated nonetheless want to check inside 72 hours earlier than boarding.

Testing guidelines have been rolled again on many cruise strains as nicely. Royal Caribbean and Celebrity require testing for unvaccinated passengers however solely require vaccinated folks to check on sailings which might be six nights or longer. Carnival, MSC Cruises and Silversea Cruises have made comparable modifications for the reason that CDC ended its COVID-19 Program for Cruise Ships. At the time this system ended final month, practically each ship that reported information to the CDC was underneath commentary for COVID-19 circumstances, The Post reported.

Starting Sept. 6, Princess Cruises would require passengers on sailings of 16 nights or longer to take a check inside three days of leaving, in addition to these on full Panama Canal transits. Unvaccinated passengers might be required to indicate a destructive check for all journeys.

Cruise corporations mentioned they count on to additional cut back a few of their restrictions in coming days, which got here in response to the CDC loosening its coronavirus suggestions for screening and testing in most settings on Thursday, the newspaper reported.

“We will continue to work closely with our partners around the world to develop updated protocols that provide for the continued safety of our guests and the communities we visit, better align with the travel and hospitality sector, and meet destination regulations,” Royal Caribbean mentioned. “This means we’re transitioning to the point where everyone will be able to vacation with us.”

The post Four Cruise Lines to Drop COVID Vaccination Requirements appeared first on Healthy and Slim Life.

WEDNESDAY, April 20, 2022 (HealthDay News) — When folks have authorized entry to marijuana, they’re much less prone to take sure pharmaceuticals, new analysis suggests.

U.S. states the place leisure marijuana is authorized have seen massive drops in the usage of pharmaceuticals for ache, despair, anxiousness, sleep, psychosis and seizures, the researchers discovered.

“These outcomes have necessary implications,” mentioned examine co-author Shyam Raman. He is a doctoral scholar within the School of Public Policy at Cornell University in Ithaca, N.Y.

“The reductions in drug utilization that we discover may result in important value financial savings for state Medicaid applications. The outcomes additionally point out a chance to scale back the hurt that may include the harmful unwanted side effects related to some pharmaceuticals,” Raman mentioned in a college information launch.

For the examine, the researchers analyzed U.S. Centers for Medicare and Medicaid Services information collected from all states from 2011 to 2019, when there was a rise in states that allow private marijuana use.

Currently, leisure marijuana use is authorized in 18 states plus Washington, D.C. Thirty-seven states plus Washington, D.C., have legalized medical marijuana.

Most earlier analysis has centered on how medical marijuana impacts prescription drug use or how authorized leisure pot use impacts opioid demand. This is likely one of the first papers to look at the affect of authorized leisure marijuana on prescription drug use, the examine authors famous.

While there’s a constructive side to their findings, the investigators warned that marijuana use carries dangers, pointing to quite a few research that join it with attainable triggering of tension and psychoses equivalent to schizophrenia.

There’s additionally the prospect that individuals who use marijuana to deal with their well being issues could not see their physician as usually, leading to gaps of their main care, the researchers mentioned.

The examine was printed April 15 within the journal Health Economics .

More data

There’s extra on marijuana on the U.S. National Institute on Drug Abuse.

SOURCE: Cornell University, information launch, April 18, 2022

The post When Pot Is Legal, Prescriptions for Pain, Depression, Anxiety and Sleep Drop appeared first on Healthy and Slim Life.

MONDAY, April 4, 2022 (HealthDay News) — Efforts to chop again on dangerous opioid use for ache after surgical procedure are trickling right down to youngsters.

New analysis reveals that fewer Americans beneath the age of 18 have been prescribed narcotics to deal with surgical ache between 2014 and 2017, and these numbers dropped much more quickly starting in late 2017.

While opioids can assist youngsters handle gentle or reasonable ache, latest research have proven that youngsters do exactly as properly with restricted or no opioids. Additionally, opioids carry their justifiable share of dangers for youths, together with respiratory despair (gradual and shallow respiration) and the potential for abuse. The U.S. Centers for Disease Control and Prevention just lately urged medical doctors to prescribe different ache medicine every time doable in an effort to assist stem the nationwide epidemic of opioid use and overdose deaths.

“Our findings recommend that surgical suppliers are prescribing fewer opioids for procedures the place they may not be wanted,” stated research writer Dr. Tori Sutherland, an attending anesthesiologist at Children’s Hospital of Philadelphia. “If applicable in your youngster, nonsteroidal anti-inflammatory medicine [NSAIDs] like ibuprofen might be pretty much as good or higher than opioids for procedures related to gentle to reasonable ache, like dental surgical procedure or adenoidectomy,” stated Sutherland.

For the research, Sutherland’s staff tapped into insurance coverage information on greater than 124,000 youngsters youthful than 18 who underwent certainly one of eight surgical procedures between 2014 and 2019, together with tonsillectomies, dental surgical procedures, appendix elimination or knee surgical procedure.

The total proportion of youngsters who had an opioid prescription stuffed within the week after their surgical procedure dropped throughout adolescents, school-aged youngsters, and preschool-aged youngsters throughout the five-year research interval.

Broken down by age group, prescriptions dropped from simply over 78% to 48% for adolescents, from practically 54% to 25.5% amongst school-aged youngsters, and from about 30% to 11.5% for preschool-aged youngsters, the investigators discovered.

What’s extra, the typical morphine milligram equal declined by roughly 50% throughout all three age teams. (Morphine is an opioid ache killer.)

Parents ought to ask about non-opioid alternate options if their youngsters are having probably painful surgical procedure, Sutherland stated.

“If the process is related to gentle to reasonable ache, and they’re allowed to take an NSAID [or Tylenol], they may not want opioids most often,” she stated. “For main surgical procedures requiring an inpatient keep, mother and father can focus on with their medical doctors if alternate options, like a nerve block or non-opioid medicines, may be applicable.”

The research was revealed on-line April 4 within the journal Pediatrics.

Dr. Lorraine Kelley-Quon is a pediatric surgeon at Children’s Hospital, Los Angeles. She has studied opioid use amongst youngsters prior to now.

“This research provides much-needed epidemiologic information outlining how opioid prescribing practices have modified in recent times for youngsters present process surgical procedure,” stated Kelley-Quon, who was not concerned with the brand new analysis. “Parents ought to proceed to interact their surgeons and well being care suppliers in discussions about find out how to safely use, retailer and eliminate prescription opioids when wanted and choices for non-opioid ache reduction methods.”

More info

The American Academy of Pediatrics presents ideas for fogeys on find out how to handle a baby’s ache after surgical procedure.

SOURCES: Tori Sutherland, MD, attending anesthesiologist, Children’s Hospital of Philadelphia; Lorraine Kelley-Quon, MD, pediatric surgeon, Children’s Hospital, Los Angeles; Pediatrics, April 4 2022, on-line

The post Big Drop Seen in Kids Getting Opioids After Surgery appeared first on Healthy and Slim Life.

Dec. 10, 2021 — The effectiveness of the 2 most typical COVID-19 vaccines declined over time in an older group of sufferers, suggesting that booster doses could also be wanted to guard recipients over the long run, in line with a brand new research.

Also seen in that group of U.S. veterans, who had a median age of 67: Those receiving “the Moderna vaccine consistently had higher antibody levels, compared with recipients of the Pfizer-BioNTech vaccine, across age groups and time since vaccination,” mentioned Kristina L. Bajema, MD, of the CDC’s COVID-19 Response Team, and associates.

Effectiveness of the Moderna vaccine was 89.6% at 14-119 days after sufferers had obtained the second dose, in contrast with 86.0% for the Pfizer vaccine. After 120 or extra days, vaccine effectiveness had dropped to 86.1% for Moderna and 75.1% for Pfizer, the investigators reported within the Morbidity and Mortality Weekly Report.

Levels of the related antibodies — anti-spike immunoglobulin (IgG) and anti-receptor binding area (RBD) IgG — confirmed an analogous sample: Lower after the 120-day mark for each vaccines, however increased at each time intervals for Moderna than for Pfizer. These variations in antibody ranges are per different research, researchers mentioned, and could also be the results of the Moderna vaccine’s increased antigen content material and its longer interval between doses.

All 1,896 veterans within the research had been enrolled whereas they had been hospitalized with COVID-like sickness at 5 Veterans Affairs medical facilities across the nation (Atlanta, Houston, Los Angeles, New York City, and Palo Alto, CA). The group included sufferers who examined constructive and people who had been detrimental for COVID-19 when first hospitalized; 799 ultimately had been absolutely vaccinated. About 58% of the group was age 65 or older.

Both vaccines had been simpler in youthful sufferers: 89.4% for these underneath 65 years and 72.9% for these 65 and older within the Pfizer group, in comparison with 94.5% and 78.6%, respectively, for Moderna. The identical drop-off in effectiveness after 120 days was seen for each age teams, the researchers famous.

The age impact could also be trigger for concern.

“Overall, for both vaccine products, antibody levels in this cohort of older U.S. veterans with high prevalences of underlying medical conditions were substantially lower than levels seen among younger, healthy volunteers or health care personnel in other studies,” they mentioned, including that booster doses could also be wanted “to help maintain long-term protection against severe COVID-19.”

The post Drop in COVID Vaccine Effectiveness Suggests Need for Boosters appeared first on Healthy and Slim Life.

Nov. 30, 2021 — The Moderna CEO says current COVID-19 vaccines will possible be much less efficient in opposition to the brand new Omicron variant.

“There is no world, I think, where [the effectiveness] is the same level … we had with Delta,” Stephane Bancel informed the Financial Times.

“I think it’s going to be a material drop,” he mentioned. “I just don’t know how much, because we need to wait for the data. But all the scientists I’ve talked to … are like, ‘This is not going to be good.’”

Vaccine firms are actually learning whether or not the brand new Omicron variant might evade the present photographs. Some knowledge is predicted in about 2 weeks.

Bancel mentioned that if a brand new vaccine is required, it might take a number of months to supply at scale. He estimated that Moderna might make billions of vaccine doses in 2022.

“[Moderna] and Pfizer cannot get a billion doses next week. The math doesn’t work,” he mentioned. “But could we get the billion doses out by the summer? Sure.”

The information brought about some panic on Tuesday, prompting monetary markets to fall sharply, based on Reuters. But the markets recovered after European officers gave a extra reassuring outlook.

“Even if the new variant becomes more widespread, the vaccines we have will continue to provide protection,” Emer Cooke, government director of the European Medicines Agency, informed the European Parliament.

Cooke mentioned the company might approve new vaccines that concentrate on the Omicron variant inside 3 to 4 months, if wanted. Moderna and Pfizer have introduced they’re starting to tailor a shot to deal with the Omicron variant in case the info reveals they’re crucial.

Also on Tuesday, the European Centre for Disease Prevention and Control introduced that 42 Omicron instances had been recognized in 10 European Union international locations, based on Reuters.

The instances had been gentle or had no signs, though they had been present in youthful individuals who could have gentle or no signs anyway.

“For the assessment of whether [Omicron] escapes immunity, we still have to wait until investigations in the laboratories with [blood samples] from people who have recovered have been carried out,” Andrea Ammon, MD, chair of the company, mentioned throughout an internet convention.

The University of Oxford, which developed a COVID-19 vaccine with AstraZeneca, mentioned on Tuesday that there’s no proof that vaccines received’t forestall extreme illness from the Omicron variant, based on Reuters.

“Despite the appearance of new variants over the past year, vaccines have continued to provide very high levels of protection against severe disease and there is no evidence so far that Omicron is any different,” the college mentioned in an announcement. “However, we have the necessary tools and processes in place for rapid development of an updated COVID-19 vaccine if it should be necessary.”

The post Moderna Warns of ‘Material Drop’ in Vaccine Efficacy Against Omicron appeared first on Healthy and Slim Life.